This site is intended for health professionals only

Editor’s pick

Boehringer Ingelheim to commence phase III study of BIBW 2992
Boehringer Ingelheim to commence phase III study of BIBW 2992
Systagenix opens head office at Gatwick
Systagenix opens head office at Gatwick
UCB launch new products and financials are on track
UCB launch new products and financials are on track
Drug maker beating the recession
Drug maker beating the recession
Pfizer backs China as world leader
Pfizer backs China as world leader
Family drops “suicide drug” case
Family drops “suicide drug” case
Lundbeck and Solvay schizophrenia treatment put on hold
Lundbeck and Solvay schizophrenia treatment put on hold
Drug firm sees profits improve
Drug firm sees profits improve
Scientists predict response to drug
Scientists predict response to drug
Good first six months in 2009 for Boehringer Ingelheim
Good first six months in 2009 for Boehringer Ingelheim
BD announces UK launch of new BD Nexiva Closed IV Catheter System
BD announces UK launch of new BD Nexiva Closed IV Catheter System
Enzyme “contributes to Alzheimer’s”
Enzyme “contributes to Alzheimer’s”
1 … 122 123 124 125 126 … 302





Be in the know
Subscribe to Hospital Pharmacy Europe newsletter and magazine
Subscribe
FOLLOW US

IMPORTANT LINKS

MORE FROM COGORA

© Cogora 2026
Cogora Limited. 1 Giltspur Street, London EC1A 9DD Registered in the United Kingdom. Reg. No. 2147432

Cogora
x